Modern haemophilia treatment: medical improvements and quality of life.
about
Self-administered C1 esterase inhibitor concentrates for the management of hereditary angioedema: usability and patient acceptanceSex ratio of the mutation frequencies in haemophilia A: coagulation assays and RFLP analysisPrimary prophylaxis for individuals with severe haemophilia: how many hospital visits could treatment prevent?Physical and psychosocial challenges in adult hemophilia patients with inhibitors.Clinimetric instruments to assess functional health status in patients with haemophilia: a literature review.Evaluation of outcome of care in patients with haemophilia.Quality of life assessment in haemophilia.Anti-hemophilic factor (recombinant), plasma/albumin-free method (octocog-alpha; ADVATE) in the management of hemophilia A.C1-inhibitor concentrate home therapy for hereditary angioedema: a viable, effective treatment option.Quality of life and sports activities in patients with haemophilia.Septic arthritis in males with haemophilia.Joint protection in haemophilia.Haemophilia prophylaxis: how can we justify the costs?Barriers and motivators of adherence to prophylactic treatment in haemophilia: a systematic review.Young adults with hemophilia in the U.S.: demographics, comorbidities, and health status.Quality-of-life differences between prophylactic and on-demand factor replacement therapy in European haemophilia patients.Impact of severe haemophilia A on patients' health status: results from the guardian(™) 1 clinical trial of turoctocog alfa (NovoEight(®) ).A longitudinal study of family structure in Swedish persons with haemophilia.Pilot testing of the 'Haemo-QoL' quality of life questionnaire for haemophiliac children in six European countries.Patient preference and ease of use for different coagulation factor VIII reconstitution device scenarios: a cross-sectional survey in five European countries.Assessment of the impact of treatment on quality of life of patients with haemophilia A at different ages: insights from two clinical trials on turoctocog alfa.Health status and satisfaction of asymptomatic HIV-positive haemophiliacs in Kyushu, Japan.Haemophilia care in Europe: the ESCHQoL study.Medical care for haemophilia.Attitudes of haemophilic patients towards their health and socio-economic problems in Iran.Quality of life in women with bleeding disorders.Development and testing of an instrument to assess the Quality of Life of Children with Haemophilia in Europe (Haemo-QoL).Clinical severity of disease, functional disability and health-related quality of life. Three-year follow-up study of 150 Finnish patients with coagulation disorders.Unravelling adherence to prophylaxis in haemophilia: a patients' perspective.Assessing the relationship between productivity levels and severity of haemophilia.Hepatitis in haemophilia.
P2860
Q28079761-1905298F-053E-48B5-8698-67C21545B26EQ33597606-B6B7E635-63E2-4B64-B1F2-6744EDEFBAFFQ33904447-FE54E2CD-670E-4863-8C3E-EE950210E66CQ33968730-67E6BDAC-1CD8-4819-99C0-D3EAC94125F1Q34637110-8EEEA490-0D72-4E02-91F0-60D89D28F4DAQ34637116-2AEA94F1-0C69-4D75-A244-EF63C0F8CC1FQ35677000-AFFE3CCA-B6E0-4C9A-9E71-6654A48F437FQ36536149-1512351A-D6CB-4625-8F7A-06323154CADDQ36687522-6DEA6673-7270-44D5-A35F-BCED10837D0DQ36904933-F1854898-6F12-4E92-97C8-420CBDE09F06Q37634189-21D9B963-50AB-4D49-8E37-10CA2C89AE9DQ37912258-D1A73EA2-4F8B-4C23-AA1E-46D3E32536E0Q38002994-A43FEE27-41F3-4E53-9385-F1F09EA8E0C6Q38070822-73C19D39-D094-4E3D-8A30-87B860808997Q40261649-A8FC9B83-6DA3-45D4-A5BA-90AB027B23DCQ40654703-4E2612FA-C36D-4737-BB79-41ABFF807135Q41441975-2E87DD4B-72D3-4DE1-8286-99484F40DC59Q42246531-79228D6D-8720-4850-91F3-6124D015ECB0Q42674765-CCB4F5FC-9445-4104-B3BF-AC1177A8AD1CQ43070772-4219512D-4F55-476A-854D-57DAC6EB649DQ43088590-F09259A6-54B3-48EF-9773-401BE04A4D3AQ43941984-E143EC2A-6C46-437B-91DC-2F54EC47C94BQ45077924-3E83BFF9-5FB0-4583-91BD-90BB85145269Q45856575-FF3BF536-D583-48DA-A7BD-291334F27C4EQ45870738-3509A6C5-3210-4D78-9D38-C67E469AF092Q45871132-89316905-15DB-4F09-BB1C-2E71A065617DQ45873263-DEEF1AAD-73E5-447D-B11F-217CA253A8B2Q45873686-5D184EC9-4312-494E-9B47-59DF5F31E224Q45874855-7E124945-62DE-45AB-874B-4165D9BD1D7DQ45879762-7946EC01-23C3-466D-91BF-4E5E0422DCDAQ45889715-80334B41-112A-42CD-9742-0E14C466C3D9
P2860
Modern haemophilia treatment: medical improvements and quality of life.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
Modern haemophilia treatment: medical improvements and quality of life.
@en
type
label
Modern haemophilia treatment: medical improvements and quality of life.
@en
prefLabel
Modern haemophilia treatment: medical improvements and quality of life.
@en
P2093
P1476
Modern haemophilia treatment: medical improvements and quality of life.
@en
P2093
Bröcker-Vriends AH
Rosendaal FR
Suurmeijer TP
Vandenbroucke JP
Varekamp I
van Dijck H
P304
P356
10.1111/J.1365-2796.1990.TB00291.X
P407
P577
1990-12-01T00:00:00Z